Novo Nordisk and Vivtex Corporation have entered into a partnership to develop next-generation oral biologic medicines for ...
Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.
Novo Nordisk is deeply undervalued, trading at distressed multiples despite a robust pipeline and strong financials. Learn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results